Raanana, Israel, Oct. 30, 2024 (GLOBE NEWSWIRE) — Polyrizon Ltd. (the “Company” or “PLRZ”), a development stage biotech company specializing in the development of innovative…
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ”
Raanana, Israel, Oct. 28, 2024 (GLOBE NEWSWIRE) — Polyrizon Ltd. (the “Company” or “PLRZ”), a development stage biotech company specializing in the development of innovative…